Company: ADZCF
Filing Date: 2025-08-19
Form Type: 424B2
Source: 0000950103-25-010460
Chunk: 6

Company: DEUTSCHE BANK AKTIENGESELLSCHAFT
Filing Date: 2025-08-19
Form: 424B2
Chunk 6
---
are unable to continue our regulated banking activities without a Resolution Measure becoming applicable to us. Under the relevant resolution
laws and regulations as applicable to us from time to time, the Securities may be subject to the powers exercised by the competent resolution
authority to: (i) write down, including to zero, of any payment (or delivery obligations) on the Securities; (ii) convert the Securities
into ordinary shares of (a) the Issuer, (b) any group entity or (c) any bridge bank or other instruments of ownership of such entities
qualifying as common equity tier 1 capital (and the issue to or conferral on the holders (including the beneficial owners) of such ordinary
shares or instruments); and/or (iii) apply any other resolution measure, including, but not limited to, any transfer of the Securities
to another entity, the amendment, modification or variation of the terms and conditions of the Securities or the cancellation of the Securities.
The write-down and conversion powers are commonly referred to as the “bail-in tool” and the bail-in tool and each of the other
resolution measures are hereinafter referred to as a “Resolution Measure.” By acquiring the Securities, you will be
bound by and will be deemed irrevocably to consent to the imposition of any Resolution Measure by the competent resolution authority as
set forth in the accompanying prospectus dated April 26, 2024. Please read the risk factor “The Securities May Be Written Down, Be Converted into Ordinary Shares or Other Instruments of Ownership or Become Subject to Other Resolution Measures. You May Lose Some or All of Your Investment If Any Such Measure Becomes Applicable to Us” in this pricing supplement.

This is only a summary,
for more information please see the accompanying prospectus dated April 26, 2024, including the risk factors beginning on page 20 of such
prospectus.

<div align='center'>PS-3</div>

| Additional Information About the Issuer and the Securities |

You should read this pricing
supplement together with underlying supplement No. 1 dated April 26, 2024, product supplement B dated April 26, 2024, the prospectus supplement
dated April 26, 2024 relating to our Senior Notes, Series A of which these Securities are a part and the prospectus dated April 26, 2024.
To the extent that disclosure in this pricing supplement is inconsistent with the disclosure in the underlying supplement, product supplement,
prospectus supplement